Applicant, as named in the Orange Book
Pharmacyclics Llc
Next listed expiry: Imbruvica on 24 Apr 2035. 3 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Imbruvica NDA 205552 · 2 strengths ibrutinib | 24 Apr 2035 patent |
| Imbruvica NDA 210563 · 3 strengths ibrutinib | 3 Sep 2036 patent |
| Imbruvica NDA 217003 ibrutinib | 14 Jun 2039 patent |
Recent events
- Imbruvica · Generic approved · ANDA 211182, Hetero Labs Ltd VApproved 8 Sep 2026Detected 25 Oct 2026